News | Structural Heart Occluders
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-approved patent foramen ovale occluder in Alabama.
February 15, 2017
Technology | Stents Bare Metal
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug Administration (FDA) approval utilizing results from the BIOHELIX-I clinical study. This stent, which has already been used to treat more than 650,000 patients worldwide, is now available in the United States.
February 15, 2017
Feature | Hybrid OR | Dave Fornell
In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve ...
February 15, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology | Implantable Cardiac Monitor (ICM)
Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic resonance (MR)-conditional heart monitor or pacing or implantable cardioverter defibrillator (ICD) system for their patients.
February 14, 2017
News | CT Angiography (CTA)
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow Inc., the HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, enabling clinicians to select an appropriate treatment.
February 14, 2017News | Hypertension
Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application to participate in the Expedited Access Pathway (EAP) program for its MobiusHD device for the treatment of resistant hypertension.
February 13, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology | Enterprise Imaging
February 13, 2017 — Vital Images Inc. announced that it will be demonstrating new image sharing capabilities for current ...
February 13, 2017
News | Cybersecurity
February 10, 2017 — With the Healthcare Information and Management Systems Society’s annual meeting (HIMSS17) scheduled ...
February 10, 2017
Feature | Heart Failure | Dave Fornell
In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is partly ...
February 10, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Cardiovascular Business | Jeff Zagoudis
Rep. Tom Price was confirmed by the U.S. Senate as the new secretary of the Department of Health and Human Services (HHS) by a 52-47 vote early Friday morning.
February 10, 2017
Technology | Enterprise Imaging
Vital Images Inc. will feature its Vitrea Modular Enterprise Imaging interoperability solutions at the 2017 Healthcare Information and Management Systems Society annual meeting (HIMSS 2017), Feb. 20–23 in Orlando, Fla.
February 09, 2017
Feature | Magnetic Resonance Imaging (MRI) | Jeff Zagoudis
February 9, 2017 — Sir Peter Mansfield, FRS, whose research aided the development of magnetic resonance imaging (MRI) in ...
February 09, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Medical 3-D Printing
When a pediatric patient at Children’s Hospital Los Angeles needed a custom-build stent to repair his pulmonary artery ...
February 09, 2017Technology
eHealth Technologies and HealtheConnections, a Syracuse-based regional health information organization (RHIO) supporting health information exchange (HIE) for the 11 counties of central and northern New York, have teamed up to share medical images across the care provider community.
February 09, 2017
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopping ...
February 09, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now